Search Results - "NUMATA, Yukio"

Plasma brain-derived neurotrophic factor levels predict the clinical outcome of depression treatment in a naturalistic study by Kurita, Masatake, Nishino, Satoshi, Kato, Maiko, Numata, Yukio, Sato, Tadahiro

“…Remission is the primary goal of treatment for major depressive disorder (MDD). However, some patients do not respond to treatment. The main purpose of this…”
Get full text

The noradrenaline metabolite MHPG is a candidate biomarker from the manic to the remission state in bipolar disorder I: a clinical naturalistic study by Kurita, Masatake, Nishino, Satoshi, Numata, Yukio, Okubo, Yoshiro, Sato, Tadahiro

“…Remission is the primary goal of treatment for bipolar disorder I (BDI). Metabolites of noradrenaline and dopamine, 3-methoxy-4-hydroxyphenylglycol (MHPG) and…”
Get full text

The noradrenaline metabolite MHPG is a candidate biomarker between the depressive, remission, and manic states in bipolar disorder I: two long-term naturalistic case reports by Kurita, Masatake, Nishino, Satoshi, Numata, Yukio, Okubo, Yoshiro, Sato, Tadahiro

“…Treatment of the depressive and manic states in bipolar disorder I (BDI) is a challenge for psychiatrists. Despite the recognized importance of the switch…”
Get full text

Efficacy and Tolerability of Risperidone, Yokukansan, and Fluvoxamine for the Treatment of Behavioral and Psychological Symptoms of Dementia: A Blinded, Randomized Trial by TERANISHI, Mika, KURITA, Masatake, NISHINO, Satoshi, TAKEYOSHI, Kenji, NUMATA, Yukio, SATO, Tadahiro, TATENO, Amane, OKUBO, Yoshiro

“…The descriptive term behavioral and psychological symptoms of dementia (BPSD) is used to cover a range of noncognitive disturbances including anxiety,…”
Get full text

Divergent effects of lithium and sodium valproate on brain-derived neurotrophic factor (BDNF) production in human astrocytoma cells at therapeutic concentrations by Nishino, Satoshi, Ohtomo, Koji, Numata, Yukio, Sato, Tadahiro, Nakahata, Norimichi, Kurita, Masatake

“…Mood stabilizers such as lithium (Li) or valproic acid (VPA) are used in the therapy of bipolar disorders, but the mechanisms by which these medicines work is…”
Get full text

Yokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function by Takeyoshi, Kenji, Kurita, Masatake, Nishino, Satoshi, Teranishi, Mika, Numata, Yukio, Sato, Tadahiro, Okubo, Yoshiro

“…Although three drugs, risperidone, yokukansan, and fluvoxamine, have shown equal efficacy in treating behavioral and psychological symptoms of dementia (BPSD)…”
Get full text

Association of mu-opioid receptor gene polymorphism A118G with alcohol dependence in a Japanese population by Nishizawa, Daisuke, Han, Wenhua, Hasegawa, Junko, Ishida, Takafumi, Numata, Yukio, Sato, Tadahiro, Kawai, Atsuko, Ikeda, Kazutaka

“…Ethanol is considered to activate the brain reward system by increasing the release of an endogenous opioid receptor ligand, beta-endorphin. The polymorphism…”
Get more information

Serum Dopamine β-Hydroxylase Activity in Developing Spontaneously Hypertensive Rats and the Effect of Salt Administration by NAGATSU, Toshiharu, KATO, Takeshi, NUMATA, Yukio, IKUTA, Keiko, UMEZAWA, Hamao, TAKEUCHI, Tomio

Get full text